Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy

This study was noteworthy because it assessed prognostic factors that would help to select elderly patients who could expect actual benefits from undergoing the different t herapeutic options available, especially HMA therapy.
Source: Annals of Hematology - Category: Hematology Source Type: research